DCDebora Chiodi

Debora Chiodi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Debora Chiodi has a total of 43 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • gem -Dimethylcarbinol: A tert -Butyl Bioisostere with Greatly Reduced Lipophilicity

    by Debora Chiodi, Yoshihiro Ishihara

    The tert-butyl group is a large substituent that could be useful in some contexts for filling protein pockets, but this highly lipophilic group typically worsens the ADMET properties of the parent scaffold. Although many bioisosteres of tert-butyl are similarly lipophilic, gem-dimethylcarbinol could be a bioisostere with greatly reduced lipophilicity, bestowing balanced properties to a lead compound. This could benefit multi-parameter optimization that includes solubility, permeability, and in vitro clearance. Although one downside of installing the gem-dimethylcarbinol group is greater efflux, making it a poor motif for CNS applications, small structural modifications could mitigate this issue. The gem-dimethylcarbinol group is not chemically reactive under physiological conditions, is not a blacklisted toxicophore, and is present in a small but growing number of approved drugs. Furthermore, the simplicity of its installation in organic chemistry makes it an attractive option as a tert-butyl bioisostere with great opportunities in medicinal chemistry.

  • Open Access

    Sequential One-Pot Oxo-Re(V)-Catalyzed Meyer–Schuster Rearrangement of Propargylic Alcohols Followed by the Conjugate Addition of Gilman Organocuprates and Hydride Reduction or by the Reaction with Hydrazine Hydrochloride to Give Pyrazoles

    by Giovanni Vidari, Alessio Porta, Debora Chiodi, Faiq H. S. Hussain, Giuseppe Zanoni

    One-pot protocols leading to target products in two or more sequential reactions, without the separation and isolation of intermediate products, are powerful synthetic tools. In fact, they surpass usual procedures based on single-step reactions in terms of efficiency, cost, and green aspects. The appeal of such methodologies is further increased with the use of catalysts, which makes the process easier and more efficient, minimizing unwanted byproducts. In this context, this paper describes three new one-pot protocols, based on an oxo-Re(V)-catalyzed Meyer–Schuster rearrangement of different secondary propargylic alcohols to the corresponding α,β-unsaturated ketones. These products, without isolation, subsequently, can undergo the 1,4-conjugate addition of a soft Gilman copper nucleophile or the intramolecular cyclocondensation with hydrazine hydrochloride to pyrazoles. Moreover, the ketone formed by the addition of a Gilman reagent can further be reduced in situ with LiAlH4 to the corresponding secondary alcohol. The remarkable aspects of these novel procedures involving two and three one-pot consecutive steps are the high overall yields, the readily available reaction conditions, and the compatible presence of two transition metallic species in the same reaction medium.

  • Parallels between the chloro and methoxy groups for potency optimization

    by Debora Chiodi, Yoshihiro Ishihara

    There are parallels between Cl and OCH 3 in the types of ligand–protein interactions they engage in. The dual electrostatic versatility of these two substituents renders them useful scouts to probe protein pockets for potency optimization.


  • Tertiary Alcohol: Reaping the Benefits but Minimizing the Drawbacks of Hydroxy Groups in Drug Discovery

    by Debora Chiodi, Yoshihiro Ishihara

    Among the smaller substituents in the medicinal chemist's toolbox, the hydroxy (OH) group can bestow one of the largest impacts in the drug-like properties of a molecule. A previous study showed that an H-to-OH structural modification effectively decreases lipophilicity, increases solubility, and decreases hERG inhibition. Despite these benefits, an OH group is not always recommended in drug molecules because it presents a metabolic "soft spot" for oxidation and glucuronidation in primary and secondary alcohols. Furthermore, the OH group presents challenges in permeability. In contrast, tertiary alcohols (3° ROH) often display an improved metabolic profile because oxidation at the 3° ROH is not possible, and the geminal alkyl groups could sterically shield the OH group from glucuronidation and permeability challenges. Through a series of matched molecular pairs, this Perspective highlights the 3° ROH as a motif that can reap the benefits but minimize the drawbacks of hydroxy groups in drug discovery.


  • Total Synthesis of Dynobactin A

    by Fabian Schneider, Yinliang Guo, You-Chen Lin, Kelly J. Eberle, Debora Chiodi, Johnathan A. Greene, Chenxin Lu, Phil S. Baran

    The first total synthesis of the potent antimicrobial agent dynobactin A is disclosed. This synthesis enlists a singular aziridine ring opening strategy to access the two disparate β-aryl-branched amino acids present within this complex decapeptide. Featuring a number of unique maneuvers to navigate inherently sensitive and epimerizable functional groups, this convergent approach proceeds in only 16 steps (LLS) from commercial materials and should facilitate the synthesis of numerous analogues for medicinal chemistry studies.


  • Open Access

    Total Synthesis of Dynobactin A

    by Fabian Schneider, Yinliang Guo, You-Chen Lin, Kelly Eberle, Debora Chiodi, Jonathan Greene, Chenxin Lu, Phil Baran

    The first total synthesis of the potent antimicrobial agent dynobactin A is disclosed. This synthesis capitalizes on the hidden symmetry present in this complex decapeptide by enlisting an aziridine ring opening strategy to access b-branched amino acids. Featuring a number of unique maneuvers to navigate inherently sensitive and epimerizable functional groups, this convergent approach proceeds in only 14 steps (LLS) from commercial materials and should facilitate the synthesis of numerous analogs for medicinal chemistry studies.


  • Atroposelective Total Synthesis of Darobactin A

    by You-Chen Lin, Fabian Schneider, Kelly J. Eberle, Debora Chiodi, Hugh Nakamura, Solomon H. Reisberg, Jason Chen, Masato Saito, Phil S. Baran

    A concise, modular synthesis of the novel antibiotic darobactin A is disclosed. The synthesis successfully forges the hallmark strained macrocyclic ring systems in a sequential fashion. Key transformations include two atroposelective Larock-based macrocyclizations, one of which proceeds with exquisite regioselectivity despite bearing an unprotected alkyne. The synthesis is designed with medicinal chemistry considerations in mind, appending key portions of the molecule at a late stage. Requisite unnatural amino acid building blocks are easily prepared in an enantiopure form using C-H activation and decarboxylative cross-coupling tactics.


  • N-Ammonium Ylide Mediators for Electrochemical C–H Oxidation

    by Masato Saito, Yu Kawamata, Michael Meanwell, Rafael Navratil, Debora Chiodi, Ethan Carlson, Pengfei Hu, Longrui Chen, Sagar Udyavara, Cian Kingston, et al.

    The site-specific oxidation of strong C(sp3)–H bonds is of uncontested utility in organic synthesis. From simplifying access to metabolites and late-stage diversification of lead compounds to truncating retrosynthetic plans, there is a growing need for new reagents and methods for achieving such a transformation in both academic and industrial circles. One main drawback of current chemical reagents is the lack of diversity with regard to structure and reactivity that prevents a combinatorial approach for rapid screening to be employed. In that regard, directed evolution still holds the greatest promise for achieving complex C–H oxidations in a variety of complex settings. Herein we present a rationally designed platform that provides a step toward this challenge using N-ammonium ylides as electrochemically driven oxidants for site-specific, chemoselective C(sp3)–H oxidation. By taking a first-principles approach guided by computation, these new mediators were identified and rapidly expanded into a library using ubiquitous building blocks and trivial synthesis techniques. The ylide-based approach to C–H oxidation exhibits tunable selectivity that is often exclusive to this class of oxidants and can be applied to real-world problems in the agricultural and pharmaceutical sectors.